Cellarity Inc.

Plus: Updates from EnPlusOne, Design, Werewolf, Ardelyx and Aim Vaccine

Program designed to reduce weight while sparing muscle mass, GI effects headed for IND next year

A company’s experimental setup and scale shape the type of AI it uses and questions it can ask

Where do you start? Patient data might sound more obvious, but human cell-based models have advantages

Across disciplines, researchers are navigating trade-offs in advancing translation that boil down to scope versus focus 

Plus: ALX hires Dillon and updates from Obsidian, YS and more

Early 2024 dealmaking activity also included Roche-MOMA, Avenzo-Allorion, AbbVie-Umoja and Boehringer-3T

Plus: Erasca promotes Morris, Lovejoy and updates from Poseida, Mithra, Tune, Cellarity and more

The percent of venture rounds raised by preclinical biotech has grown over the last five years

Plus Flagship’s Cellarity raises $121M series C and updates for Inhibrx, Autolus, Vir, Ginkgo and more